David T. Winn

High-resolution functional proteomics by active-site peptide profiling

Eric Okerberg, Jiangyue Wu, Baohong Zhang et al. · Proceedings of the National Academy of Sciences · 2005 · 107 citations · Full text

Molecular Biology, Proteomic Technology, Active-site Peptide Profiling +18

First-in-Class Pan Caspase Inhibitor Developed for the Treatment of Liver Disease

Steven D. Linton, Teresa Aja, Robert A. Armstrong et al. · Journal of Medicinal Chemistry · 2005 · 105 citations

Pathology, Pharmacotherapy, Oxidative Stress +18

Synthesis of high specific activity tritium-labeled [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties

Marcus F. Boehm, Michael McClurg, Charles Pathirana et al. · Journal of Medicinal Chemistry · 1994 · 83 citations · Full text

Nonsteroidal androgen receptor agonists based on 4-(trifluoromethyl)-2H-pyrano[3,2-g]quinolin-2-one

James P. Edwards, Robert I. Higuchi, David T. Winn et al. · Bioorganic & Medicinal Chemistry Letters · 1999 · 48 citations · Full text

Medicine, Hormonal Receptor, Pharmacotherapy +4

Nonsteroidal progesterone receptor antagonists based on a conformationally-restricted subseries of 6-aryl-1,2-dihydro-2,2,4-trimethylquinolines

Lawrence G. Hamann, David T. Winn, Charlotte L. F. Pooley et al. · Bioorganic & Medicinal Chemistry Letters · 1998 · 22 citations · Full text

Medicine, Hormonal Receptor, Conformationally-restricted Subseries +5